These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 17395427)

  • 1. Hypermetabolism predicts reduced transplant-free survival independent of MELD and Child-Pugh scores in liver cirrhosis.
    Mathur S; Peng S; Gane EJ; McCall JL; Plank LD
    Nutrition; 2007 May; 23(5):398-403. PubMed ID: 17395427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis.
    Mathur S; Gane EJ; McCall JL; Plank LD
    J Gastroenterol Hepatol; 2008 Feb; 23(2):239-43. PubMed ID: 17489965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
    Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
    J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
    Farnsworth N; Fagan SP; Berger DH; Awad SS
    Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS; Jiang JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
    Schepke M; Roth F; Fimmers R; Brensing KA; Sudhop T; Schild HH; Sauerbruch T
    Am J Gastroenterol; 2003 May; 98(5):1167-74. PubMed ID: 12809844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate determination of energy needs in hospitalized patients.
    Boullata J; Williams J; Cottrell F; Hudson L; Compher C
    J Am Diet Assoc; 2007 Mar; 107(3):393-401. PubMed ID: 17324656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
    Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients.
    Wang AY; Sea MM; Tang N; Sanderson JE; Lui SF; Li PK; Woo J
    J Am Soc Nephrol; 2004 Dec; 15(12):3134-43. PubMed ID: 15579517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.
    Cholongitas E; Senzolo M; Patch D; Kwong K; Nikolopoulou V; Leandro G; Shaw S; Burroughs AK
    Aliment Pharmacol Ther; 2006 Apr; 23(7):883-93. PubMed ID: 16573791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater travel time to a liver transplant center does not adversely affect clinical outcomes.
    Firozvi AA; Lee CH; Hayashi PH
    Liver Transpl; 2008 Jan; 14(1):18-24. PubMed ID: 18161800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation.
    Degré D; Bourgeois N; Boon N; Le Moine O; Louis H; Donckier V; El Nakadi I; Closset J; Lingier P; Vereerstraeten P; Gelin M; Adler M
    Transpl Int; 2004 Jan; 17(1):31-8. PubMed ID: 14745489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
    Kikuchi LO; Paranaguá-Vezozzo DC; Chagas AL; Mello ES; Alves VA; Farias AQ; Pietrobon R; Carrilho FJ
    J Clin Gastroenterol; 2009 Feb; 43(2):191-5. PubMed ID: 19142170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.